References
- First Humira biosimilars reach EU market . www.pmlive.com/pharma_news/first_humira_biosimilars_reach_eu_market_1255952 .
- Regional Medicines Optimisation Committee Briefing . Best Value Biologicals: Adalimumab Update 1 . www.sps.nhs.uk/wp-content/uploads/2018/03/Adalimumab-RMOC-Briefing-Final-27-March.pdf .
- Agreement with Grünenthal for rights to Nexium in Europe and Vimovo worldwide (ex-US) . www.astrazeneca.com/content/astraz/media-centre/press-releases/2018/agreement-with-grunenthal-for-rights-to-nexium-in-europe-and-vimovo-worldwide-ex-us-30102018.html .
- Bain Capital and Pfizer create Cerevel Therapeutics, new CNS company . www.pfizer.com/news/press-release/press-release-detail/bain_capital_and_pfizer_create_cerevel_therapeutics_new_cns_company .
- 23andMe granted the first and only FDA authorization for Direct-to-Consumer Pharmacogenetics Reports . https://blog.23andme.com/news/23andme-granted-the-first-and-only-fda-authorization-for-direct-to-consumer-pharmacogenetics-reports/ .
- FDA authorizes first direct-to-consumer test for detecting genetic variants that may be associated with medication metabolism. https://www.fda.gov/NewsEvents/Newsroom/PressAnnouncements/ucm624753.htm .
- Digital health ecosystem gets a boost with the Novartis Biome . www.novartis.com/stories/discovery/digital-health-ecosystem-gets-boost-novartis-biome .
- Novo Nordisk plans first global launch of connected insulin pens and announces key digital health partnerships . www.novonordisk.com/content/Denmark/HQ/www-novonordisk-com/en_gb/home/media/news-details.2218400.html .
- Phillips-Medisize connected health platform now available for customized connected health solutions www.phillipsmedisize.com/insights/corporate-news/2018/october/phillips-medisize-connected-health-platform-now-available-for-customized-connected-health-solutions .
- Phillips-Medisize partners with InterSystems in connected health platform www.businesswire.com/news/home/20181008005194/en/Phillips-Medisize-Partners-InterSystems-Connected-Health-Platform .
- Novartis announces FDA and EMA filing acceptance of siponimod, the first and only drug shown to meaningfully delay disability progression in typical SPMS patients . www.novartis.com/news/media-releases/novartis-announces-fda-and-ema-filing-acceptance-siponimod-first-and-only-drug-shown-meaningfully-delay-disability-progression-typical-spms-patients .
- FDA approves new drug to treat influenza . www.fda.gov/NewsEvents/Newsroom/PressAnnouncements/ucm624226.htm .
- U.S. FDA approves INVOKANA® (canagliflozin) to reduce the risk of heart attack, stroke or cardiovascular death in adults with Type 2 diabetes and established cardiovascular disease . http://files.shareholder.com/downloads/JNJ/6419837489x0x984510/15609F03-ACE3-4193-9328-27EACF35566E/INVOKANA_CANVAS_FDA_Approval_Final_10.30.18.pdf .
- OCREVUS (ocrelizumab) data show early initiation of treatment reduces disability progression over five years in relapsing and primary progressive multiple sclerosis . www.roche.com/media/releases/med-cor-2018-10-10.htm .
- Survey results presented at ECTRIMS reveal people with multiple sclerosis want more information on brain atrophy . https://ir.celgene.com/press-releases/press-release-details/2018/Survey-Results-Presented-at-ECTRIMS-Reveal-People-with-Multiple-Sclerosis-Want-More-Information-on-Brain-Atrophy/default.aspx .
- Breadth of data at ECTRIMS underpins Novartis’ relentless commitment to decoding the science of multiple sclerosis (MS) and decreasing the patient burden . www.novartis.com/news/media-releases/breadth-data-ectrims-underpins-novartis-relentless-commitment-decoding-science-multiple-sclerosis-ms-and-decreasing-patient-burden .
- Plog BA Mestre H Olveda GE et al. Transcranial optical imaging reveals a pathway for optimizing the delivery of immunotherapeutics to the brain . JCI Insight3 ( 20 ), e120922 ( 2018 ).